HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukemic transformation of Langerhans cell sarcoma.

Abstract
A 57-year-old man became aware of left supraclavicular lymph node swelling, which was subsequently diagnosed as Langerhans cell sarcoma, based on a positive immunophenotype for CD1a, S-100 protein, and langerin, and histologically bizarre pleomorphism. The tumor became leukemic 3 months later. Despite intensive chemotherapy, he died of disease progression 7 months after the initial diagnosis. Tumor cells in the leukemic phase expressed CD5, CD7, CD13, CD33, CD34, CD68, and CD123. These findings suggested leukemic transformation from Langerhans cell sarcoma. Leukemic transformation may be a clinical manifestation of advanced Langerhans cell sarcoma, and should be differentiated from acute myelogenous leukemia.
AuthorsKousuke Sumida, Yuya Yoshidomi, Hiroko Koga, Nobuo Kuwahara, Eijo Matsuishi, Kennosuke Karube, Koichi Oshima, Hisashi Gondo
JournalInternational journal of hematology (Int J Hematol) Vol. 87 Issue 5 Pg. 527-531 (Jun 2008) ISSN: 0925-5710 [Print] Japan
PMID18360746 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD
Topics
  • Antigens, CD (immunology)
  • Diagnosis, Differential
  • Fatal Outcome
  • Humans
  • Immunophenotyping (methods)
  • Langerhans Cell Sarcoma (immunology, pathology)
  • Leukemia, Myeloid, Acute (immunology, pathology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: